SCHEMBL21787569

SCHEMBL21787569

CNC(=O)COc1cc2cc([N+](=O)[O-])c(F)cc2n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL6 P41182 6/20 0.42
NCOR2 Q9Y618 4/20 0.41
MELK Q14680 1/20 0.41
MAPT P10636 6/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 2/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
RAPGEF3 O95398 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FAAH O00519 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20267661 0.87 BCL6 (0.47) BCL6NCOR2MELKMAPTALDH1A1
SCHEMBL21787618 0.87 BCL6 (0.42) BCL6NCOR2MELKMAPTALDH1A1
SCHEMBL20284508 0.82 BCL6 (0.44) BCL6NCOR2MELKALDH1A1HTT
SCHEMBL20267284 0.81 BCL6 (0.49) BCL6NCOR2MELKMAPTALDH1A1
SCHEMBL29874501 0.81 BCL6 (0.49) BCL6NCOR2MELKMAPTALDH1A1
SCHEMBL21787625 0.74 KDM4E (0.49) MAPTALDH1A1KDM4EHTTLMNA
SCHEMBL23267671 0.74 BCL6 (0.55) BCL6NCOR2MELKMAPTKDM4E
SCHEMBL20284512 0.73 BCL6 (0.44) BCL6NCOR2MELKALDH1A1SMN1; SMN2
SCHEMBL20267506 0.73 BCL6 (0.50) BCL6NCOR2MELKALDH1A1LMNA
SCHEMBL21774738 0.73 MAPT (0.41) BCL6NCOR2MELKMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-05-11 US disclosed
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071297-A1 NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS BCL6, BCL6B, BCOR BCL6 1/4885NCOR2 101/4885MELK 393/4885
US-11001570-B2 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors BCL6, BCL6B, BCOR BCL6 1/4885NCOR2 90/4885MELK 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.